Betamethasone + NeomycinThird Party Manufacturing in India

This combination formulation acts through two distinct pathways to treat local inflammation complicated by bacterial infection. Betamethasone is a highly potent synthetic corticosteroid that exerts anti-inflammatory, antipruritic, and vasoconstrictive effects. It works by entering target cells and binding to cytoplasmic glucocorticoid receptors, which then translocation into the cell nucleus to modulate gene expression. This inhibits the synthesis of inflammatory mediators like prostaglandins and leukotrienes by blocking phospholipase A2 activity and downregulating pro-inflammatory cytokines, which reduces swelling, redness, and itching. Neomycin, a broad-spectrum aminoglycoside antibiotic, complements this action by targeting susceptible bacterial pathogens. It binds irreversibly to the 30S ribosomal subunit of bacterial cells, which disrupts mRNA translation. This leads to the production of nonfunctional proteins and the disruption of the bacterial cell membrane, resulting in bacterial cell death. The simultaneous action of these two agents effectively manages the underlying allergic or inflammatory response while eradicating concurrent bacterial infections in cutaneous, ocular, or otic tissues, preventing further tissue damage and accelerating recovery.

Therapeutic Uses

Betamethasone and Neomycin is indicated for:

• Steroid-Responsive Ocular Inflammation: Treats conditions like allergic conjunctivitis, blepharitis, and uveitis when a bacterial infection is present or suspected.
• Otitis Externa: Manages acute and chronic external ear infections accompanied by severe inflammation, swelling, and itching.
• Inflammatory Skin Conditions: Treats eczema, psoriasis, contact dermatitis, and other inflammatory rashes prone to secondary bacterial infection.

Why Manufacturers Choose This Combination

This combination of a potent steroid and a broad-spectrum antibiotic remains a staple in clinical practice for eye/ear infections and dermatological conditions due to its reliable dual action. It is highly valued for its efficacy in resolving acute discomfort and infection rapidly, maintaining a steady and high volume of prescriptions globally.

Distributors and marketing companies select Betamethasone + Neomycin third party manufacturing in India to capture a large share of the ophthalmic, otic, and topical cream markets. Our associated manufacturing plants run WHO-GMP certified operations, employing advanced sterile filling lines for eye/ear drops and specialized ointment/cream compounding suites. Sourcing from a WHO-GMP certified partner ensures that the formulation complies with national and international regulatory standards, supporting seamless distribution in domestic and export markets.